Infectious pseudotumors: red herrings in head and neck pathology

Samir K El-Mofty1, Shreeram Akilesh

  • 1Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA. elmofty@wustl.edu

Insights

Infectious pseudotumors can mimic cancer due to atypical cell growth. Recognizing these infections is crucial for effective antibiotic treatment, preventing misdiagnosis of malignant neoplasms.

Area of Science:

  • Pathology
  • Infectious Diseases
  • Oncology

Background:

  • Infectious pseudotumors are tumor-like lesions caused by microbial agents.
  • Proliferating histiocytes in these lesions can exhibit atypical cytology, mimicking malignancy.
  • Immunohistochemical profiles may further complicate diagnosis, suggesting various neoplastic processes.

Observation:

  • Two cases are presented: an endotracheal mass in an AIDS patient caused by Rhodococcus equi and a nasal mass with Klebsiella rhinoscleromatis.
  • Cytological atypia and immunohistochemical findings in both cases initially suggested malignancies like carcinoma, sarcoma, chordoma, and paraganglioma.
  • Microbial virulence factors contributed to intracellular survival and histiocytic proliferation.

Findings:

  • Rhodococcus equi infection presented as an obstructive endotracheal mass with atypical histiocytes resembling oncocytic carcinoma or rhabdomyosarcoma.
  • Klebsiella rhinoscleromatis infection manifested as a nasal mass with features mimicking chordoma and paraganglioma.
  • Both infections demonstrated prolonged intracellular survival due to microbial virulence factors affecting phagocytosis, leading to histiocytic proliferation.

Implications:

  • Surgical pathologists must be aware that certain infectious processes can clinically and microscopically resemble malignant neoplasms.
  • Accurate identification of infectious pseudotumors and their causative agents is critical for appropriate management.
  • Prompt diagnosis and treatment with antibiotics can lead to successful resolution of these lesions, avoiding unnecessary oncological interventions.